A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

After starting therapy for psoriasis, Asempa usually has a follow-up visit at 3 to 4 months. Patient feedback at that point carries a lot of weight with respect to next steps.

Discover a study that demonstrates the effectiveness of guselkumab in treating scalp psoriasis, offering significant symptom ...

BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by head-to-head studies showing it was more effective at treating moderate-to-severe psoriasis than ...

Just a few weeks after its approval in the UK, Bristol-Myers Squibb’s new oral psoriasis therapy Sotyktu has been recommended for routine NHS in England and Wales. The National ...

Generally, credit card issuers will look at your credit score, income, recent credit applications and credit history when approving you for a new card. Keep in mind that while your FICO credit ...

The Patient Health Questionnaire (PHQ) is often a first-choice tool used by primary care professionals for most people. This is because it can help diagnose depression between 78% and 94% of the time.

After two years, 1 in 4 people with psoriasis change from one biologic to another. Doing so can help improve your quality of life. Here’s what to know if you have to make a switch. [1] ...

2025 FIFA Club World Cup schedule, scores Semifinal schedule Match 61: Fluminense vs Chelsea — Tuesday, July 8, 3pm ET, MetLife Stadium, East Rutherford — Preview, live updates, videos Match 62: PSG ...